Industry Insight: June 2026 Update: Health Canada Provides Updates on Human Drug Submission Workload Management

Industry Insight: June 2026 Update: Health Canada Provides Updates on Human Drug Submission Workload Management

As of June 2026, Health Canada is advancing workload management measures intended to address human drug submission backlogs, improve review predictability, and support more transparent communication with sponsors. These measures include enhanced communication protocols, expanded reliance approaches, HTA alignment, and operational review efficiencies, while maintaining Health Canada’s review standards for…
Read More
Industry Insight: June 2026 Update: Health Canada Discusses GMP Inspection Trends, Quality System Expectations, and Compliance Priorities for DEL

Industry Insight: June 2026 Update: Health Canada Discusses GMP Inspection Trends, Quality System Expectations, and Compliance Priorities for DEL

On Tuesday June 23, 2026, at the Pharmaceutical Sciences Group’s (PSG) 9th Annual Day with Health Canada, Karolina Zarichna from Source Nutraceutical, Inc. (SNI) attended discussions on recent Good Manufacturing Practices (GMP) inspection trends and compliance expectations for Canadian and foreign drug establishments.  Health Canada provided insight into inspection observations…
Read More
Industry Insight: June 2026 Update: Health Canada Discusses the Future of NHP Regulation

Industry Insight: June 2026 Update: Health Canada Discusses the Future of NHP Regulation

At the Pharmaceutical Sciences Group’s (PSG) 9th Annual Day with Health Canada Tuesday June 23, 2026, Karolina Zarichna from Source Nutraceutical, Inc. (SNI) attended discussions on the evolving direction of Canada’s Natural Health Product (NHP) regulatory framework.  Health Canada highlighted a continued shift toward a more risk-based and proportionate approach to NHP…
Read More
What Evidence Do You Need to Substantiate Veterinary Health Product (VHP) Claims in Canada?

What Evidence Do You Need to Substantiate Veterinary Health Product (VHP) Claims in Canada?

In Canada, Veterinary Health Product (VHP) claims must be supported by objective and credible evidence aligned with the product’s ingredients, conditions of use, and intended purpose. Claims should focus on maintaining or promoting animal health and must not represent the product as treating, diagnosing, mitigating, preventing, or curing disease. Introduction…
Read More
Health Canada Updates FPS Expectations for NHP Applications

Health Canada Updates FPS Expectations for NHP Applications

As of June 15, 2026, Health Canada no longer expects finished product specifications (FPS) to be submitted upfront with Class II and Class III NHP product licence applications (PLAs) or amendments. However, an FPS must still be established, maintained, and provided to Health Canada upon request. Introduction Health Canada has…
Read More
How to Prepare for a Health Canada NHP Site Licence Inspection 

How to Prepare for a Health Canada NHP Site Licence Inspection 

To sell a natural health product (NHP) in Canada, companies must consider both product licensing and site licensing requirements. A product licence authorizes the sale of a specific NHP, while a site licence is required for the Canadian physical site where NHPs are manufactured, packaged, labelled, or imported for sale.  Obtaining these licences requires…
Read More
Industry Trusted Food Label Review Services in Canada – Confident Market Entry!

Industry Trusted Food Label Review Services in Canada – Confident Market Entry!

Food labels in Canada are regulated consumer-facing materials that carry both technical and commercial weight. They must accurately communicate the identity of the product, its composition, the responsible party, applicable use or storage information, and any claims or representations made to consumers.  For food brands, importers, distributors, and retailers, a…
Read More
Health Canada Melatonin Update: Pediatric Use to Become Prescription-Only 

Health Canada Melatonin Update: Pediatric Use to Become Prescription-Only 

Health Canada has announced an amendment to the human use section of the Prescription Drug List for “melatonin or its salts.” Effective June 2, 2026, melatonin products sold for sleep-related use in children and adolescents under 18 years of age will be classified as prescription drugs under the Food and Drug…
Read More
How to Launch a Compliant Food Product in Canada: Understanding Current Canadian Food Labelling Regulations

How to Launch a Compliant Food Product in Canada: Understanding Current Canadian Food Labelling Regulations

For food brands entering the Canadian market, success hinges on more than taste and presentation, it depends on regulatory compliance, especially when it comes to product labels. Whether you’re a startup launching your first SKU or a multinational expanding your line, your product label is one of the most scrutinized…
Read More
How to Comply with Energy Drink Regulations in Canada 

How to Comply with Energy Drink Regulations in Canada 

Energy drinks have become one of the most visible beverage categories in Canada, driven by new flavours, functional positioning, and growing consumer demand for products associated with energy, focus, and performance. Yet despite strong consumer demand, many brands enter the market without a regulatory and commercialization strategy designed for long-term success. …
Read More